Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2024-05-30 00:00:00 ET · period of report 2024-05-28 · accession 0001048477-24-000112 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-30 | 2024-05-28 | BMRN | Davis George Eric | EVP, CLO | M - OptEx | $63.10 | +40.9K | 97.0K | +73% | +$2.58M |
| DM | 2024-05-30 | 2024-05-28 | BMRN | Davis George Eric | EVP, CLO | S - Sale+OE | $74.52 | -40.9K | 58.9K | -41% | -$3.04M |
| D | 2024-05-30 | 2024-05-28 | BMRN | Davis George Eric | EVP, CLO | M - OptEx | $0.00 | -40.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-28 | M | A | 40,850 | $63.10 | 97,007 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on September 13, 2023. |
| 2 | Common | Common Stock | 2024-05-28 | S | D | 2,779 | $75.29 | 56,157 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on September 13, 2023. (F3) The price in column 4 is the weighted average price. The purchase price actually received ranged from $75.00 to $75.735. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. |
| 3 | Common | Common Stock | 2024-05-28 | S | D | 38,071 | $74.46 | 58,936 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on September 13, 2023. (F2) The price in column 4 is the weighted average price. The purchase price actually received ranged from $74.12 to $74.99. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. |
| 4 | Derivative | Stock Option (Right to Buy Common Stock) | 2024-05-28 | M | D | 40,850 | $0.00 | 0 | D | $63.10 · 2014-12-04 to 2024-06-30 | 40,850 Common Stock | (F4) Reflects the number of options outstanding after the transactions from this specific stock option grant. |